Atlas Trials

Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects

Clinical trial NCT03770039 · COMPLETED

Trial details

NCT number
NCT03770039
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Male Subjects
Start date
2018-12-10
Primary completion
2019-02-21
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.